Cargando…

Real-World Experience With Collagenase Clostridium Histolyticum-aaes for Buttock and Thigh Cellulite: Focus on Administration and Safety Profile

BACKGROUND: Collagenase clostridium histolyticum-aaes (CCH-aaes) is approved for the treatment of moderate-to-severe buttock cellulite in adult women. OBJECTIVES: To report on real-world experience with CCH-aaes in the treatment of buttock and thigh cellulite. METHODS: Retrospective analysis of medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shridharani, Sachin M, Kennedy, MacKenzie L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108883/ https://www.ncbi.nlm.nih.gov/pubmed/37077934 http://dx.doi.org/10.1093/asjof/ojad014

Ejemplares similares

Evaluation of five collagenase clostridium histolyticum‐aaes injection techniques for the treatment of cellulite on the buttock or thigh
por: Kaufman‐Janette, Joely, et al.
Publicado: (2022)

Characterization of Tissue Histology for the Injectable Cellulite Treatment Collagenase Clostridium Histolyticum-aaes: Results in Swine
por: Shridharani, Sachin M, et al.
Publicado: (2023)

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite
por: Kaufman-Janette, Joely A., et al.
Publicado: (2020)

Collagenase Clostridium histolyticum for the Treatment of Cellulite in the Buttocks and Thigh: Early Insights From Clinical Practice
por: Graivier, Miles, et al.
Publicado: (2022)

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
por: Bass, Lawrence S., et al.
Publicado: (2022)

Enzymatic Subcision and Remodeling after Collagenase Clostridium histolyticum-Aaes Subcutaneous Injection: Updated Evidence from Porcine and Human Studies
por: Sachin, Shridharani, et al.
Publicado: (2021)

Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

New Considerations in the Use of Collagenase Clostridium Histolyticum for the Treatment of Cellulite
por: Grekin, Jeremy A, et al.
Publicado: (2023)

Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH‐aaes)
por: Wolfe, Henry R., et al.
Publicado: (2021)

Collagenase Clostridium Histolyticum for the Treatment of Edematous Fibrosclerotic Panniculopathy (Cellulite): A Randomized Trial
por: Sadick, Neil S., et al.
Publicado: (2019)

Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015)

Monitoring the Degradation of Collagen Hydrogels by Collagenase Clostridium histolyticum
por: Ng, Hon Wei, et al.
Publicado: (2020)

Intralesional collagenase clostridium histolyticum study provides real-world analysis
por: Haney, Nora M., et al.
Publicado: (2016)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Collagenase Clostridium histolyticum : emerging practice patterns and treatment advances
por: Warwick, David, et al.
Publicado: (2016)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
por: Kuhlmann, Paige K, et al.
Publicado: (2017)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016)

Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie's Disease in the United States
por: Sun, Andrew J., et al.
Publicado: (2019)

Peyronie’s disease – outcomes of collagenase clostridium histolyticum injection: A systematic review
por: Mefford, Austin T., et al.
Publicado: (2021)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
por: Gannon, Margaret K., et al.
Publicado: (2021)

Hyperdilute calcium hydroxyapatite for treatment of cellulite dimples in the buttock
por: Niaz, Ghassan, et al.
Publicado: (2023)

Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie’s disease
por: Diao, Linley, et al.
Publicado: (2017)

Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017)

Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017)

Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie’s disease
por: Aliperti, Louis A., et al.
Publicado: (2017)

Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2022)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
por: Geelhoed, Jeannette P., et al.
Publicado: (2022)

Safety of Xiaflex® (Collagenase Clostridium histolyticum) Treatment for Adult Anterior Urethral Stricture Disease
por: Wiegand, Lucas R, et al.
Publicado: (2023)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option
por: Gabrielson, Andrew T, et al.
Publicado: (2017)

Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren’s disease in 788 patients: the Austrian register
por: Rohit, Arora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kd8qv90k4n1rub6379i3m2b1nh